BRCA1 andBRCA2 genes: Role in hereditary breast and ovarian cancer in Italy
Manuela Santarosa(Centro di Riferimento Oncologico), Alessandra Viel(Centro di Riferimento Oncologico), Daniela Furlan(University of Insubria), Riccardo Dolcetti(Translational Research Institute), Lara Della Puppa(National Cancer Institute), Angelo Gallo(Centro di Riferimento Oncologico), Salvatore Tumolo, Mauro Boiocchi(Centro di Riferimento Oncologico), Maria Grazia Tibiletti(University of Insubria), Diana Crivellari(Centro di Riferimento Oncologico), Maria Donatella Magri(Centro di Riferimento Oncologico)
International Journal of Cancer
September 24, 1999
Cited by 58
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII
|Journal of Clinical Oncology|2000|295
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
|The Lancet|2000|286
Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
|British Journal of Haematology|2005|193